	Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities. Biochim Biophys Acta Rev Cancer Deng S, Li Y, Peng L, Li J, Zhang L. PMID: 41765207 [PubMed - as supplied by publisher]
	Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing. Lung Cancer Citarella F, Venanzi FM, Di Giovanni G, Takada K, Cascetta P, Crucitti P, Lintas C, Fiorenti M, Mingo EC, La Cava G, Russano M, Pantano F, Vincenzi B, Tonini G, Vavalà T, Milanesi E, Oresti S, Crinò L, Delmonte A, Ferrara R, Di Maio M, Gurrieri F, Cortellini A. PMID: 41764946 [PubMed - as supplied by publisher]
	Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study. Lung Cancer Toda M, Takada K, Nomura K, Kosai K, Hayasaka K, Watanabe T, Takamori S, Hamada A, Suda K, Ohara S, Ito M, Oiki H, Fukami T, Muto S, Katsumata S, Konno H, Toyoda T, Endo M, Takamori S, Nakatsuka M, Tenpaku H, Takegahara K, Matsubara T, Kinoshita F, Akamine T, Nakamura R, Mizuno K, Nakagawa K, Kaneda S, Okada S, Notsuda H, Sakane T, Shinohara S, Abe M, Haratake N, Tane S, Hanawa R, Ito A, Namba K, Kawaguchi T, Minegishi K, Kurihara N, Iguchi T, Aokage K, Tsuboi M, Iwata T, Soh J, Shimokawa M, Ohde Y. PMID: 41764944 [PubMed - as supplied by publisher]
	Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial). J Transl Med Piedra A, Guinart-Cuadra A, Martínez-Recio S, Mulet M, Zamora C, Osuna-Gómez R, Cantó E, Ortiz MA, Alejandre J, Barba A, Sanz-Beltrán J, Serra-López J, Isla D, Arriola E, Paz-Ares L, Diz-Taín MP, Moreno AL, Callejo Á, Vidal S, Majem M. PMID: 41764558 [PubMed - as supplied by publisher]
	Diagnostic Utility of Expression Imbalance in Idylla GeneFusion Assay for Non-Small Cell Lung Cancer. J Mol Diagn Stram MN, Caffes PL, Lo YC. PMID: 41763606 [PubMed - as supplied by publisher]
	Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies. Cancer Lett Yan JS, Wang YZ, Zhao SY, Na FJ, Cui ZX, Cai LT, Li HM, Zhao MF. PMID: 41763450 [PubMed - as supplied by publisher]
	Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial. Thromb Res Sato T, Ogihara Y, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T, Dohi K, ONCO PE Trial Investigators. PMID: 41762931 [PubMed - as supplied by publisher]
	The effectiveness of the AI-based RehabLung mobile rehabilitation system on cardiopulmonary function and user satisfaction in lung cancer patients undergoing thoracic surgery: a protocol for a two-arm randomized clinical trial. Ther Adv Respir Dis Yang HL, Hung CH, Huang YT, Cheng HC, Tseng YL, Su JM, Tsai KL. PMID: 41762649 [PubMed - in process]
	Integrating network pharmacology and Mendelian randomization to explore potential targets of Fufang Banmao capsule against non-small cell lung cancer. Pak J Pharm Sci Wei Z, Hu Y, Zuo F, Liu C, Wu D, Sun X. PMID: 41761800 [PubMed - in process]
	Triangulating Associations Between Fruit Intake and Lung Cancer Risk: Evidence from GBD Estimates, Mendelian Randomization, and Real-World Validation. Oncologist Liu M, Hu Q, Zhang X, Wu Z, Wang S, Hu Y, Xu S, Xu Z, Luo J, Sun L. PMID: 41761571 [PubMed - as supplied by publisher]
	Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational Study. Cancer Med Hsu PC, Ko HW, Chiu LC, Huang SH, Lee CS, Lin YC, Kuo SC, Ju JS, Wang CC, Yang CT. PMID: 41761381 [PubMed - in process]
	Feasibility and preliminary efficacy of an art-making program to manage fear of cancer recurrence (AM-I-FCR) in lung cancer patients: a randomized controlled pilot study. BMC Med Lin J, Kang Z, Zhang C, Arbing R, Chen WT, Huang F. PMID: 41761252 [PubMed - as supplied by publisher]
	Efficacy and tolerability of first-line treatment regimens for extensive-stage small cell lung cancer - a grade-assessed network meta-analysis of randomized controlled trials. BMC Cancer Najah Q, Makhlouf HA, Osman ASA, Almosilhy NA, Abusalah MA, Abuhlaiga MA, Qutob IA, Abdelgawad HAH. PMID: 41761164 [PubMed - as supplied by publisher]
	SLC and ABC Transporters in Lung Cancer: Orchestrators of Malignancy and Therapeutic Resistance. Compr Physiol Li P, Dong M, Chen B, Luo J, Jiang H, Lin N. PMID: 41761042 [PubMed - in process]
	Efficacy and safety of tepotinib in METâ€‘altered nonâ€‘small cell lung cancer: a meta-analysis. Sci Rep Xiao J, Cai Q, Li X, Zhang D. PMID: 41760894 [PubMed - as supplied by publisher]
	Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study. Clin Lung Cancer Mountzios G, Weng JK, Zairi E, Hsieh K, Chander P, Dunlop W, Qiao Y, Wang A, Januszewski A. PMID: 41760536 [PubMed - as supplied by publisher]
	ScRNA-Seq: A way to reveal the potential mechanisms of metastasis in small cell lung cancer. Bull Cancer Guan XL, Gan DX, Wu Y, Zhang Y. PMID: 41760455 [PubMed - as supplied by publisher]
	History of Chronic Obstructive Pulmonary Disease May Contribute to Earlier Diagnosis of Lung Cancer. In Vivo Marel M, Domecky P, Fernando CML, Bejckova A, Fila L, Hrnciarik M, Vencalek T, Roubec J, Duba J, Svaton M. PMID: 41760320 [PubMed - in process]
	Mechanistic Studies of Anticancer Effects of Salicylaldehyde Benzoylhydrazone in 2D/3D Lung Cancer Cell Cultures. Anticancer Res Sangseekew W, Boonsombat J, Thongnest S, Sirirak J, Sornprachum T, Lirdprapamongkol K, Svasti J, Ruchirawat S, Keeratichamroen S. PMID: 41760238 [PubMed - in process]
	Cost Evaluation of a Multimodal Prehabilitation Program for High-risk Lung Cancer Surgery. J Thorac Cardiovasc Surg Ghezeljeh TN, Cho AR, Guigui A, Douglas L, Schwartzman K, Ramanakumar AV, Tsang J, Ferri L, Cools-Lartigue J, Spicer JD, Najmeh S, Carli F. PMID: 41759946 [PubMed - as supplied by publisher]

Articles 1 - 20 / 156697

Page 1 of 7835



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy